Bayforest Capital Ltd Invests $38,000 in Axcelis Technologies, Inc. $ACLS

Bayforest Capital Ltd bought a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 764 shares of the semiconductor company’s stock, valued at approximately $38,000.

A number of other large investors have also modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Axcelis Technologies by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company’s stock worth $220,530,000 after buying an additional 43,768 shares in the last quarter. Reinhart Partners LLC. raised its stake in shares of Axcelis Technologies by 39.1% during the 1st quarter. Reinhart Partners LLC. now owns 1,441,022 shares of the semiconductor company’s stock worth $71,576,000 after buying an additional 404,910 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Axcelis Technologies by 7.6% during the 1st quarter. American Century Companies Inc. now owns 1,140,495 shares of the semiconductor company’s stock worth $56,648,000 after buying an additional 80,399 shares in the last quarter. Boston Trust Walden Corp raised its stake in shares of Axcelis Technologies by 0.8% during the 1st quarter. Boston Trust Walden Corp now owns 826,332 shares of the semiconductor company’s stock worth $41,044,000 after buying an additional 6,216 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Axcelis Technologies by 7.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock worth $31,560,000 after buying an additional 44,275 shares in the last quarter. 89.98% of the stock is owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Performance

Axcelis Technologies stock opened at $85.55 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.26 and a current ratio of 6.01. The stock has a fifty day moving average of $77.42 and a two-hundred day moving average of $64.30. The company has a market capitalization of $2.69 billion, a price-to-earnings ratio of 17.49 and a beta of 1.73. Axcelis Technologies, Inc. has a fifty-two week low of $40.40 and a fifty-two week high of $110.17.

Axcelis Technologies (NASDAQ:ACLS) last released its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.40. The company had revenue of $194.54 million during the quarter, compared to the consensus estimate of $185.15 million. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.Axcelis Technologies’s revenue was down 24.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.55 earnings per share. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. On average, analysts anticipate that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. DA Davidson increased their target price on Axcelis Technologies from $75.00 to $90.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. B. Riley raised their price objective on Axcelis Technologies from $58.00 to $75.00 and gave the company a “neutral” rating in a research note on Wednesday, June 18th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $90.00.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.